Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 4:39 PM
Ignite Modification Date:
2025-12-24 @ 4:39 PM
NCT ID:
NCT05940766
Eligibility Criteria:
Inclusion Criteria:
* Chemotherapy treatment because of any malignancy expected to last ≥2 months at time of recruitment for myelosuppressive therapy, or at least 1 cycle of myeloablative chemotherapy followed by hematopoietic stem cell transplantation
* Age ≥1 month and \<18 years at time of recruitment
* Written informed consent from patients and/or parents
Exclusion Criteria:
* Neonates \<1 months
* Local skin disease prohibiting wearing of the WD
* Denied written informed consent from patients and/or parents
* Inclusion of vulnerable participants mandatory as vital signs and FN episodes differ significantly in children and adults
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
1 Month
Maximum Age:
17 Years
Study:
NCT05940766
Study Brief:
Protocol Section:
NCT05940766